Literature DB >> 11966779

Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantation.

Y Sugawara1, M Makuuchi, J Kaneko, T Ohkubo, H Imamura, H Kawarasaki.   

Abstract

The optimal doses of tacrolimus (FK) needed to reach and maintain a target blood level vary among cases of living donor liver transplantation (LDLT). One hundred and twenty four LDLTs in 122 patients were included in this study. Tacrolimus was administered by continuous intravenous infusion at a rate of 2.5 microg/kg/h just after the operation. The time needed to reach the target blood level and the dose needed to maintain this level for 1 week (17-18 ng/mL) were defined as the initial duration (ID) and secondary dose (SD), respectively. In the first 100 LDLTs, the correlations between ID or SD and some clinical factors were examined and equations for predicting ID or SD were derived. In the latest 24 LDLTs, FK was administered using these equations and the actual and calculated ID and SD values were compared. A multiple regression analysis revealed that only the graft weight/recipient standard liver volume (GW/SLV) ratio (%) correlated with ID or SD. Stepwise regression analysis led to the equations ID (h) = 0.4 x GW/SLV ratio + 0.2; SD (microg/kg/h) = 0.02 x GW/SLV ratio - 0.4. Simple regression analysis revealed a significant correlation between the actual and calculated ID and SD values (p < 0.0001). Initial duration and SD can be estimated from equations using the GW/SLV ratio.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11966779     DOI: 10.1034/j.1399-0012.2002.1o106.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  13 in total

1.  Resection of a pulmonary lesion after liver transplantation: report of a case.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Jun Nakajima; Yoji Kishi; Takashi Niiya; Junichi Kaneko; Masatoshi Makuuchi
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

2.  Late mortality from thrombotic microangiopathy after liver transplantation: report of a case.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Sumihito Tamura; Junichi Togashi; Junichi Kaneko; Masatoshi Makuuchi
Journal:  Surg Today       Date:  2007-03-26       Impact factor: 2.549

3.  Total body propofol clearance (TBPC) after living-donor liver transplantation (LDLT) surgery is decreased in patients with a long warm ischemic time.

Authors:  Wael S Al-Jahdari; Fumio Kunimoto; Shigeru Saito; Koujirou Yamamoto; Hiroshi Koyama; Ryuya Horiuchi; Fumio Goto
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

Review 4.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts.

Authors:  Fei Liu; Ya Li; Xiang Lan; Yong-Gang Wei; Bo Li; Lv-Nan Yan; Tian-Fu Wen; Ji-Chun Zhao; Ming-Qing Xu; Wen-Tao Wang; Jia-Yin Yang
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

6.  Clostridium difficile-associated diarrhea after living donor liver transplantation.

Authors:  Masao Hashimoto; Yasuhiko Sugawara; Sumihito Tamura; Junichi Kaneko; Yuichi Matsui; Junichi Togashi; Masatoshi Makuuch
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

7.  Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.

Authors:  Dirk R J Kuypers; Kathleen Claes; Pieter Evenepoel; Bart Maes; Willy Coosemans; Jacques Pirenne; Yves Vanrenterghem
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients.

Authors:  Nastya Kassir; Line Labbé; Jean-Romain Delaloye; Mohamad-Samer Mouksassi; Anne-Laure Lapeyraque; Fernando Alvarez; Michel Lallier; Mona Beaunoyer; Yves Théorêt; Catherine Litalien
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

9.  Acquisition of methicillin-resistant Staphylococcus aureus after living donor liver transplantation: a retrospective cohort study.

Authors:  Masao Hashimoto; Yasuhiko Sugawara; Sumihito Tamura; Junichi Kaneko; Yuichi Matsui; Junichi Togashi; Kyoji Moriya; Kazuhiko Koike; Masatoshi Makuuchi
Journal:  BMC Infect Dis       Date:  2008-11-11       Impact factor: 3.090

10.  On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosis.

Authors:  Robert J Greenstein; Liya Su; Ramon A Juste; Sheldon T Brown
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.